US$ 27.68
glp 1 fgf21 agonist boehringer Mechanistic interplay among THRβ agonist, analogues and GLP-1RA Targeting GLP-1, GIP & GCG
Description
Sciacca, L

A critical review

Which GLP-1 is Right For You

Silverii GA, Marinelli C, Mannucci E, Rotella F

Tang H, et al

Biologic agents targeting specific inflammatory pathwaysincluding TNF- inhibitors (adalimumab, etanercept), IL-6 inhibitors (tocilizumab), T-cell costimulation modulators (abatacept), and B-cell depleting agents (rituximab)provide additional options for patients with inadequate response to conventional therapy
